Management of severe paediatric malaria in resource-limited settings

Area of Science:

• Pediatrics
• Infectious Diseases
• Tropical Medicine

Background:

• Severe Plasmodium falciparum malaria disproportionately affects young children in sub-Saharan Africa, causing significant hospital admissions and mortality.
• Management in resource-poor settings often relies on basic supportive care and parenteral antimalarials due to limited access to intensive care.
• Previous research has focused on antimalarial treatments and supportive therapies, with varying degrees of success.

Purpose of the Study:

• To review the spectrum of severe malaria complications in African children.
• To analyze therapeutic challenges in resource-limited settings.
• To evaluate clinical trial outcomes to inform treatment priorities and future research.

Main Methods:

• Review of clinical trial data, focusing on the AQUAMAT trial (2010) comparing artesunate and quinine.
• Analysis of pathophysiology-based supportive therapy trials.
• Synthesis of evidence on complications and management strategies.

Main Results:

• The AQUAMAT trial demonstrated a 22.5% lower relative risk of death with artesunate compared to quinine in children.
• Supportive therapies, despite some morbidity benefits, have not consistently reduced mortality and have sometimes led to adverse outcomes.
• Significant challenges exist in managing severe malaria in resource-poor African settings.

Conclusions:

• Artesunate is a more effective antimalarial treatment than quinine for severe Plasmodium falciparum malaria in children.
• Further research is needed to improve the efficacy of supportive care and address management challenges.
• Prioritizing effective antimalarial treatment and developing better supportive strategies are crucial for reducing mortality.